Amir Reza Jalilian Selected Research

lutetium ethylenediaminetetramethylene phosphonic acid

1/2016	Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
4/2015	Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats.
1/2012	Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Reza Jalilian Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2007
6	Pain (Aches) 01/2016 - 01/2012
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
3	Fibrosarcoma 04/2012 - 01/2007
2	Necrosis 01/2017 - 10/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2014 - 04/2013
1	Heart Failure 01/2017
1	Hypertrophy 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2017
1	Thyroid Neoplasms (Thyroid Cancer) 01/2016
1	Thyrotoxicosis 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Infections 01/2015
1	Multiple Myeloma 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2014
1	Lymphoma (Lymphomas) 04/2013

Drug/Important Bio-Agent (IBA)

6	RadiopharmaceuticalsIBA 01/2022 - 01/2007
5	Radioisotopes (Radionuclides)IBA 01/2016 - 01/2012
4	Monoclonal AntibodiesIBA 01/2022 - 04/2013
3	Gallium-68IBA 01/2019 - 01/2015
3	lutetium ethylenediaminetetramethylene phosphonic acidIBA 01/2016 - 01/2012
3	LigandsIBA 12/2015 - 01/2007
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2014
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2017 - 04/2013
2	Calcium Channels (Calcium Channel)IBA 01/2017 - 10/2016
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2017 - 10/2016
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2016 - 07/2014
2	Biological ProductsIBA 12/2015 - 04/2012
2	Organophosphonates (Phosphonates)IBA 12/2015 - 05/2014
2	phosphonic acidIBA 04/2015 - 01/2015
2	Rituximab (Mabthera)FDA Link 07/2014 - 04/2013
2	CationsIBA 01/2012 - 01/2012
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2017
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2017
1	Etidronic Acid (HEDP)FDA LinkGeneric 01/2016
1	SulfurIBA 01/2016
1	Colloids (Colloid)IBA 01/2016
1	Copper-64IBA 01/2016
1	Diphosphonates (Bisphosphonates)IBA 04/2015
1	Citric Acid (Citrate)FDA LinkGeneric 01/2015
1	tetramethylenedisulfotetramine (DSTA)IBA 01/2015
1	holmium- 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetrakis(methylenephosphonic acid)IBA 12/2014
1	Immunoconjugates (Immunoconjugate)IBA 07/2014
1	samarium Sm-153 lexidronam (Quadramet)FDA Link 05/2014
1	Samarium-153IBA 05/2014
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 05/2014
1	human ERBB2 proteinIBA 01/2014
1	PorphyrinsIBA 01/2013
1	Aromatic HydrocarbonsIBA 04/2012
1	thiazolyl blueIBA 04/2012
1	Gallium-67IBA 04/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2012
1	acetyl acetonate (acetylacetonate)IBA 01/2012
1	ThiosemicarbazonesIBA 01/2012
1	Zinc-68IBA 01/2007
1	copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complexIBA 01/2007
1	Acetates (Acetic Acid Esters)FDA Link 01/2007

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2007
3	Radioimmunotherapy 01/2022 - 04/2013